Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms

被引：102

作者：

Katragkou, Aspasia ^{[1
]}

Chatzimoschou, Athanasios ^{[1
]}

Simitsopoulou, Maria ^{[1
]}

Dalakiouridou, Maria ^{[1
]}

Diza-Mataftsi, Eudoxia ^{[2
]}

Tsantali, Chaido ^{[3
]}

Roilides, Emmanuel ^{[1
]}

机构：

[1] Aristotle Univ Thessaloniki, Dept Pediat 3, Hippokrat Hosp, Infect Dis Lab, GR-54642 Thessaloniki, Greece

[2] Aristotle Univ Thessaloniki, Dept Microbiol 1, Thessaloniki 54124, Greece

[3] Aristotle Univ Thessaloniki, Dept Pediat 1, Hippokrat Hosp, Thessaloniki 54642, Greece

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2008年 / 52卷 / 01期

关键词：

D O I：

10.1128/AAC.00856-07

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The activities of voriconazole, posaconazole, caspofungin, and anidulafungin against Candida albicans and Candida parapsilosis biofilms were evaluated. In contrast to planktonic cells, the MICs for voriconazole and posaconazole for the biofilms of the two species were high (>= 256 and >64 mg/liter, respectively) but relatively low for the echinocandins caspofungin and anidulafungin (<= 1 and <= 2 mg/liter, respectively).

引用

页码：357 / 360

页数：4

共 17 条

[11] Candida biofilm:: a well-designed protected environment [J].

Mukherjee, PK ;

Zhou, GY ;

Munyon, R ;

Ghannoum, MA .

MEDICAL MYCOLOGY, 2005, 43 (03) :191-208

[12] Candida biofilm resistance [J].

Mukherjee, PK ;

Chandra, J .

DRUG RESISTANCE UPDATES, 2004, 7 (4-5) :301-309

[13]

National Committee for Clinical Laboratory Standards, 2002, M27A2 NAT COMM CLIN

[14] Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States [J].

Ostrosky-Zeichner, L ;

Rex, JH ;

Pappas, PG ;

Hamill, RJ ;

Larsen, RA ;

Horowitz, HW ;

Powderly, WG ;

Hyslop, N ;

Kauffman, CA ;

Cleary, J ;

Mangino, JE ;

Lee, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (10) :3149-3154

[15] Intravascular-catheter-related infections [J].

Raad, I .

LANCET, 1998, 351 (9106) :893-898

[16] Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms [J].

Ramage, G ;

vande Walle, K ;

Wickes, BL ;

López-Ribot, JL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (09) :2475-2479

[17] Paradoxical effect of caspofungin:: Reduced activity against Candida albicans at high drug concentrations [J].

Stevens, DA ;

Espiritu, M ;

Parmar, R .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) :3407-3411

← 1 2 →